カテゴリー： 世界, 医療/バイオ, LP Information

世界の医薬品微結晶セルロース市場予測 2023年-2029年

【英語タイトル】Global Pharmaceutical Microcrystalline Cellulose Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC02438）・商品コード：LP23DC02438
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：111
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医療機器＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の医薬品微結晶セルロース市場」は、過去の販売実績から2022年の世界の医薬品微結晶セルロースの総販売量を検討し、2023年から2029年の予測される医薬品微結晶セルロースの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の医薬品微結晶セルロースの市場規模を掲載し、XXX百万米ドル規模の世界の医薬品微結晶セルロース市場の詳細な分析を提供します。本インサイトレポートは、世界の医薬品微結晶セルロース業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の医薬品微結晶セルロース市場における各社の独自のポジションをより深く理解するために、医薬品微結晶セルロース製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の医薬品微結晶セルロース市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。医薬品微結晶セルロースの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。医薬品微結晶セルロースの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。医薬品微結晶セルロースのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

医薬品微結晶セルロースの世界主要メーカーとしては、International Flavors & Fragrances、 JRS Pharma、 Shin-Etsu Chemical Co., Ltd.、 Ashland、 Asahi Kasei、 Mingtai、 Huzhou Zhanwang、 Sunhere Pharmaceutical Excipients、 Shandong HEAD、 Lotte Chemicals、 Shandong Liaocheng E HUA Pharmaceutical Co., Ltd、 Yingkou AODA Pharmaceuticals、 Accent Microcell、 Qufu TIANLI MEDICAL Supplements、 C & J Chemical Industries Co., Ltd.などを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の医薬品微結晶セルロース市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では医薬品微結晶セルロース市場をセグメンテーションし、種類別 (粒径50ミクロン以下、粒径50-100ミクロン、粒径100ミクロン以上)、用途別 (徐放性製剤、錠剤、カプセル剤)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：粒径50ミクロン以下、粒径50-100ミクロン、粒径100ミクロン以上

・用途別区分：徐放性製剤、錠剤、カプセル剤

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の医薬品微結晶セルロース市場の10年間の市場状況・展望は？
・世界および地域別に見た医薬品微結晶セルロース市場成長の要因は何か？
・医薬品微結晶セルロースの市場機会はエンドマーケットの規模によってどのように変化するのか？
・医薬品微結晶セルロースのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：医薬品微結晶セルロースの年間販売量2018-2029、地域別現状・将来分析
・医薬品微結晶セルロースの種類別セグメント：粒径50ミクロン以下、粒径50-100ミクロン、粒径100ミクロン以上
・医薬品微結晶セルロースの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・医薬品微結晶セルロースの用途別セグメント：徐放性製剤、錠剤、カプセル剤
・医薬品微結晶セルロースの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の医薬品微結晶セルロース市場
・企業別のグローバル医薬品微結晶セルロース市場データ：2018-2023年の年間販売量、市場シェア
・企業別の医薬品微結晶セルロースの年間売上：2018-2023年の売上、市場シェア
・企業別の医薬品微結晶セルロース販売価格
・主要企業の医薬品微結晶セルロース生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

医薬品微結晶セルロースの地域別レビュー
・地域別の医薬品微結晶セルロース市場規模2018-2023：年間販売量、売上
・主要国別の医薬品微結晶セルロース市場規模2018-2023：年間販売量、売上
・南北アメリカの医薬品微結晶セルロース販売の成長
・アジア太平洋の医薬品微結晶セルロース販売の成長
・ヨーロッパの医薬品微結晶セルロース販売の成長
・中東・アフリカの医薬品微結晶セルロース販売の成長

南北アメリカ市場
・南北アメリカの国別の医薬品微結晶セルロース販売量、売上（2018-2023）
・南北アメリカの医薬品微結晶セルロースの種類別販売量
・南北アメリカの医薬品微結晶セルロースの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の医薬品微結晶セルロース販売量、売上（2018-2023）
・アジア太平洋の医薬品微結晶セルロースの種類別販売量
・アジア太平洋の医薬品微結晶セルロースの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の医薬品微結晶セルロース販売量、売上（2018-2023）
・ヨーロッパの医薬品微結晶セルロースの種類別販売量
・ヨーロッパの医薬品微結晶セルロースの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の医薬品微結晶セルロース販売量、売上（2018-2023）
・中東・アフリカの医薬品微結晶セルロースの種類別販売量
・中東・アフリカの医薬品微結晶セルロースの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・医薬品微結晶セルロースの製造コスト構造分析
・医薬品微結晶セルロースの製造プロセス分析
・医薬品微結晶セルロースの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・医薬品微結晶セルロースの主要なグローバル販売業者
・医薬品微結晶セルロースの主要なグローバル顧客

地域別の医薬品微結晶セルロース市場予測レビュー
・地域別の医薬品微結晶セルロース市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・医薬品微結晶セルロースの種類別市場規模予測
・医薬品微結晶セルロースの用途別市場規模予測

主要企業分析
International Flavors & Fragrances、 JRS Pharma、 Shin-Etsu Chemical Co., Ltd.、 Ashland、 Asahi Kasei、 Mingtai、 Huzhou Zhanwang、 Sunhere Pharmaceutical Excipients、 Shandong HEAD、 Lotte Chemicals、 Shandong Liaocheng E HUA Pharmaceutical Co., Ltd、 Yingkou AODA Pharmaceuticals、 Accent Microcell、 Qufu TIANLI MEDICAL Supplements、 C & J Chemical Industries Co., Ltd.
・企業情報
・医薬品微結晶セルロース製品
・医薬品微結晶セルロース販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Pharmaceutical Microcrystalline Cellulose market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Pharmaceutical Microcrystalline Cellulose is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pharmaceutical Microcrystalline Cellulose is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pharmaceutical Microcrystalline Cellulose is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pharmaceutical Microcrystalline Cellulose players cover International Flavors & Fragrances, JRS Pharma, Shin-Etsu Chemical Co., Ltd., Ashland, Asahi Kasei, Mingtai, Huzhou Zhanwang, Sunhere Pharmaceutical Excipients and Shandong HEAD, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Pharmaceutical Microcrystalline Cellulose Industry Forecast” looks at past sales and reviews total world Pharmaceutical Microcrystalline Cellulose sales in 2022, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Microcrystalline Cellulose sales for 2023 through 2029. With Pharmaceutical Microcrystalline Cellulose sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Microcrystalline Cellulose industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceutical Microcrystalline Cellulose landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceutical Microcrystalline Cellulose portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceutical Microcrystalline Cellulose market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Microcrystalline Cellulose and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Microcrystalline Cellulose.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Microcrystalline Cellulose market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Particle Size Less Than 50 Microns
Particle Size 50-100 Microns
Particle Size Greater Than 100 Microns
Segmentation by application
Sustained Release Preparation
Tablet
Capsule
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
International Flavors & Fragrances
JRS Pharma
Shin-Etsu Chemical Co., Ltd.
Ashland
Asahi Kasei
Mingtai
Huzhou Zhanwang
Sunhere Pharmaceutical Excipients
Shandong HEAD
Lotte Chemicals
Shandong Liaocheng E HUA Pharmaceutical Co., Ltd
Yingkou AODA Pharmaceuticals
Accent Microcell
Qufu TIANLI MEDICAL Supplements
C & J Chemical Industries Co., Ltd.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Pharmaceutical Microcrystalline Cellulose market?
What factors are driving Pharmaceutical Microcrystalline Cellulose market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pharmaceutical Microcrystalline Cellulose market opportunities vary by end market size?
How does Pharmaceutical Microcrystalline Cellulose break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pharmaceutical Microcrystalline Cellulose Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Pharmaceutical Microcrystalline Cellulose by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Pharmaceutical Microcrystalline Cellulose by Country/Region, 2018, 2022 & 2029
2.2 Pharmaceutical Microcrystalline Cellulose Segment by Type
2.2.1 Particle Size Less Than 50 Microns
2.2.2 Particle Size 50-100 Microns
2.2.3 Particle Size Greater Than 100 Microns
2.3 Pharmaceutical Microcrystalline Cellulose Sales by Type
2.3.1 Global Pharmaceutical Microcrystalline Cellulose Sales Market Share by Type (2018-2023)
2.3.2 Global Pharmaceutical Microcrystalline Cellulose Revenue and Market Share by Type (2018-2023)
2.3.3 Global Pharmaceutical Microcrystalline Cellulose Sale Price by Type (2018-2023)
2.4 Pharmaceutical Microcrystalline Cellulose Segment by Application
2.4.1 Sustained Release Preparation
2.4.2 Tablet
2.4.3 Capsule
2.5 Pharmaceutical Microcrystalline Cellulose Sales by Application
2.5.1 Global Pharmaceutical Microcrystalline Cellulose Sale Market Share by Application (2018-2023)
2.5.2 Global Pharmaceutical Microcrystalline Cellulose Revenue and Market Share by Application (2018-2023)
2.5.3 Global Pharmaceutical Microcrystalline Cellulose Sale Price by Application (2018-2023)
3 Global Pharmaceutical Microcrystalline Cellulose by Company
3.1 Global Pharmaceutical Microcrystalline Cellulose Breakdown Data by Company
3.1.1 Global Pharmaceutical Microcrystalline Cellulose Annual Sales by Company (2018-2023)
3.1.2 Global Pharmaceutical Microcrystalline Cellulose Sales Market Share by Company (2018-2023)
3.2 Global Pharmaceutical Microcrystalline Cellulose Annual Revenue by Company (2018-2023)
3.2.1 Global Pharmaceutical Microcrystalline Cellulose Revenue by Company (2018-2023)
3.2.2 Global Pharmaceutical Microcrystalline Cellulose Revenue Market Share by Company (2018-2023)
3.3 Global Pharmaceutical Microcrystalline Cellulose Sale Price by Company
3.4 Key Manufacturers Pharmaceutical Microcrystalline Cellulose Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pharmaceutical Microcrystalline Cellulose Product Location Distribution
3.4.2 Players Pharmaceutical Microcrystalline Cellulose Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Pharmaceutical Microcrystalline Cellulose by Geographic Region
4.1 World Historic Pharmaceutical Microcrystalline Cellulose Market Size by Geographic Region (2018-2023)
4.1.1 Global Pharmaceutical Microcrystalline Cellulose Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Pharmaceutical Microcrystalline Cellulose Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Pharmaceutical Microcrystalline Cellulose Market Size by Country/Region (2018-2023)
4.2.1 Global Pharmaceutical Microcrystalline Cellulose Annual Sales by Country/Region (2018-2023)
4.2.2 Global Pharmaceutical Microcrystalline Cellulose Annual Revenue by Country/Region (2018-2023)
4.3 Americas Pharmaceutical Microcrystalline Cellulose Sales Growth
4.4 APAC Pharmaceutical Microcrystalline Cellulose Sales Growth
4.5 Europe Pharmaceutical Microcrystalline Cellulose Sales Growth
4.6 Middle East & Africa Pharmaceutical Microcrystalline Cellulose Sales Growth
5 Americas
5.1 Americas Pharmaceutical Microcrystalline Cellulose Sales by Country
5.1.1 Americas Pharmaceutical Microcrystalline Cellulose Sales by Country (2018-2023)
5.1.2 Americas Pharmaceutical Microcrystalline Cellulose Revenue by Country (2018-2023)
5.2 Americas Pharmaceutical Microcrystalline Cellulose Sales by Type
5.3 Americas Pharmaceutical Microcrystalline Cellulose Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical Microcrystalline Cellulose Sales by Region
6.1.1 APAC Pharmaceutical Microcrystalline Cellulose Sales by Region (2018-2023)
6.1.2 APAC Pharmaceutical Microcrystalline Cellulose Revenue by Region (2018-2023)
6.2 APAC Pharmaceutical Microcrystalline Cellulose Sales by Type
6.3 APAC Pharmaceutical Microcrystalline Cellulose Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pharmaceutical Microcrystalline Cellulose by Country
7.1.1 Europe Pharmaceutical Microcrystalline Cellulose Sales by Country (2018-2023)
7.1.2 Europe Pharmaceutical Microcrystalline Cellulose Revenue by Country (2018-2023)
7.2 Europe Pharmaceutical Microcrystalline Cellulose Sales by Type
7.3 Europe Pharmaceutical Microcrystalline Cellulose Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pharmaceutical Microcrystalline Cellulose by Country
8.1.1 Middle East & Africa Pharmaceutical Microcrystalline Cellulose Sales by Country (2018-2023)
8.1.2 Middle East & Africa Pharmaceutical Microcrystalline Cellulose Revenue by Country (2018-2023)
8.2 Middle East & Africa Pharmaceutical Microcrystalline Cellulose Sales by Type
8.3 Middle East & Africa Pharmaceutical Microcrystalline Cellulose Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pharmaceutical Microcrystalline Cellulose
10.3 Manufacturing Process Analysis of Pharmaceutical Microcrystalline Cellulose
10.4 Industry Chain Structure of Pharmaceutical Microcrystalline Cellulose
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pharmaceutical Microcrystalline Cellulose Distributors
11.3 Pharmaceutical Microcrystalline Cellulose Customer
12 World Forecast Review for Pharmaceutical Microcrystalline Cellulose by Geographic Region
12.1 Global Pharmaceutical Microcrystalline Cellulose Market Size Forecast by Region
12.1.1 Global Pharmaceutical Microcrystalline Cellulose Forecast by Region (2024-2029)
12.1.2 Global Pharmaceutical Microcrystalline Cellulose Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pharmaceutical Microcrystalline Cellulose Forecast by Type
12.7 Global Pharmaceutical Microcrystalline Cellulose Forecast by Application
13 Key Players Analysis
13.1 International Flavors & Fragrances
13.1.1 International Flavors & Fragrances Company Information
13.1.2 International Flavors & Fragrances Pharmaceutical Microcrystalline Cellulose Product Portfolios and Specifications
13.1.3 International Flavors & Fragrances Pharmaceutical Microcrystalline Cellulose Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 International Flavors & Fragrances Main Business Overview
13.1.5 International Flavors & Fragrances Latest Developments
13.2 JRS Pharma
13.2.1 JRS Pharma Company Information
13.2.2 JRS Pharma Pharmaceutical Microcrystalline Cellulose Product Portfolios and Specifications
13.2.3 JRS Pharma Pharmaceutical Microcrystalline Cellulose Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 JRS Pharma Main Business Overview
13.2.5 JRS Pharma Latest Developments
13.3 Shin-Etsu Chemical Co., Ltd.
13.3.1 Shin-Etsu Chemical Co., Ltd. Company Information
13.3.2 Shin-Etsu Chemical Co., Ltd. Pharmaceutical Microcrystalline Cellulose Product Portfolios and Specifications
13.3.3 Shin-Etsu Chemical Co., Ltd. Pharmaceutical Microcrystalline Cellulose Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Shin-Etsu Chemical Co., Ltd. Main Business Overview
13.3.5 Shin-Etsu Chemical Co., Ltd. Latest Developments
13.4 Ashland
13.4.1 Ashland Company Information
13.4.2 Ashland Pharmaceutical Microcrystalline Cellulose Product Portfolios and Specifications
13.4.3 Ashland Pharmaceutical Microcrystalline Cellulose Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Ashland Main Business Overview
13.4.5 Ashland Latest Developments
13.5 Asahi Kasei
13.5.1 Asahi Kasei Company Information
13.5.2 Asahi Kasei Pharmaceutical Microcrystalline Cellulose Product Portfolios and Specifications
13.5.3 Asahi Kasei Pharmaceutical Microcrystalline Cellulose Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Asahi Kasei Main Business Overview
13.5.5 Asahi Kasei Latest Developments
13.6 Mingtai
13.6.1 Mingtai Company Information
13.6.2 Mingtai Pharmaceutical Microcrystalline Cellulose Product Portfolios and Specifications
13.6.3 Mingtai Pharmaceutical Microcrystalline Cellulose Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Mingtai Main Business Overview
13.6.5 Mingtai Latest Developments
13.7 Huzhou Zhanwang
13.7.1 Huzhou Zhanwang Company Information
13.7.2 Huzhou Zhanwang Pharmaceutical Microcrystalline Cellulose Product Portfolios and Specifications
13.7.3 Huzhou Zhanwang Pharmaceutical Microcrystalline Cellulose Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Huzhou Zhanwang Main Business Overview
13.7.5 Huzhou Zhanwang Latest Developments
13.8 Sunhere Pharmaceutical Excipients
13.8.1 Sunhere Pharmaceutical Excipients Company Information
13.8.2 Sunhere Pharmaceutical Excipients Pharmaceutical Microcrystalline Cellulose Product Portfolios and Specifications
13.8.3 Sunhere Pharmaceutical Excipients Pharmaceutical Microcrystalline Cellulose Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Sunhere Pharmaceutical Excipients Main Business Overview
13.8.5 Sunhere Pharmaceutical Excipients Latest Developments
13.9 Shandong HEAD
13.9.1 Shandong HEAD Company Information
13.9.2 Shandong HEAD Pharmaceutical Microcrystalline Cellulose Product Portfolios and Specifications
13.9.3 Shandong HEAD Pharmaceutical Microcrystalline Cellulose Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Shandong HEAD Main Business Overview
13.9.5 Shandong HEAD Latest Developments
13.10 Lotte Chemicals
13.10.1 Lotte Chemicals Company Information
13.10.2 Lotte Chemicals Pharmaceutical Microcrystalline Cellulose Product Portfolios and Specifications
13.10.3 Lotte Chemicals Pharmaceutical Microcrystalline Cellulose Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Lotte Chemicals Main Business Overview
13.10.5 Lotte Chemicals Latest Developments
13.11 Shandong Liaocheng E HUA Pharmaceutical Co., Ltd
13.11.1 Shandong Liaocheng E HUA Pharmaceutical Co., Ltd Company Information
13.11.2 Shandong Liaocheng E HUA Pharmaceutical Co., Ltd Pharmaceutical Microcrystalline Cellulose Product Portfolios and Specifications
13.11.3 Shandong Liaocheng E HUA Pharmaceutical Co., Ltd Pharmaceutical Microcrystalline Cellulose Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Shandong Liaocheng E HUA Pharmaceutical Co., Ltd Main Business Overview
13.11.5 Shandong Liaocheng E HUA Pharmaceutical Co., Ltd Latest Developments
13.12 Yingkou AODA Pharmaceuticals
13.12.1 Yingkou AODA Pharmaceuticals Company Information
13.12.2 Yingkou AODA Pharmaceuticals Pharmaceutical Microcrystalline Cellulose Product Portfolios and Specifications
13.12.3 Yingkou AODA Pharmaceuticals Pharmaceutical Microcrystalline Cellulose Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Yingkou AODA Pharmaceuticals Main Business Overview
13.12.5 Yingkou AODA Pharmaceuticals Latest Developments
13.13 Accent Microcell
13.13.1 Accent Microcell Company Information
13.13.2 Accent Microcell Pharmaceutical Microcrystalline Cellulose Product Portfolios and Specifications
13.13.3 Accent Microcell Pharmaceutical Microcrystalline Cellulose Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Accent Microcell Main Business Overview
13.13.5 Accent Microcell Latest Developments
13.14 Qufu TIANLI MEDICAL Supplements
13.14.1 Qufu TIANLI MEDICAL Supplements Company Information
13.14.2 Qufu TIANLI MEDICAL Supplements Pharmaceutical Microcrystalline Cellulose Product Portfolios and Specifications
13.14.3 Qufu TIANLI MEDICAL Supplements Pharmaceutical Microcrystalline Cellulose Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Qufu TIANLI MEDICAL Supplements Main Business Overview
13.14.5 Qufu TIANLI MEDICAL Supplements Latest Developments
13.15 C & J Chemical Industries Co., Ltd.
13.15.1 C & J Chemical Industries Co., Ltd. Company Information
13.15.2 C & J Chemical Industries Co., Ltd. Pharmaceutical Microcrystalline Cellulose Product Portfolios and Specifications
13.15.3 C & J Chemical Industries Co., Ltd. Pharmaceutical Microcrystalline Cellulose Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 C & J Chemical Industries Co., Ltd. Main Business Overview
13.15.5 C & J Chemical Industries Co., Ltd. Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Pharmaceutical Microcrystalline Cellulose Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Pharmaceutical Microcrystalline Cellulose Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Particle Size Less Than 50 Microns
Table 4. Major Players of Particle Size 50-100 Microns
Table 5. Major Players of Particle Size Greater Than 100 Microns
Table 6. Global Pharmaceutical Microcrystalline Cellulose Sales by Type (2018-2023) & (Tons)
Table 7. Global Pharmaceutical Microcrystalline Cellulose Sales Market Share by Type (2018-2023)
Table 8. Global Pharmaceutical Microcrystalline Cellulose Revenue by Type (2018-2023) & ($ million)
Table 9. Global Pharmaceutical Microcrystalline Cellulose Revenue Market Share by Type (2018-2023)
Table 10. Global Pharmaceutical Microcrystalline Cellulose Sale Price by Type (2018-2023) & (US$/Ton)
Table 11. Global Pharmaceutical Microcrystalline Cellulose Sales by Application (2018-2023) & (Tons)
Table 12. Global Pharmaceutical Microcrystalline Cellulose Sales Market Share by Application (2018-2023)
Table 13. Global Pharmaceutical Microcrystalline Cellulose Revenue by Application (2018-2023)
Table 14. Global Pharmaceutical Microcrystalline Cellulose Revenue Market Share by Application (2018-2023)
Table 15. Global Pharmaceutical Microcrystalline Cellulose Sale Price by Application (2018-2023) & (US$/Ton)
Table 16. Global Pharmaceutical Microcrystalline Cellulose Sales by Company (2018-2023) & (Tons)
Table 17. Global Pharmaceutical Microcrystalline Cellulose Sales Market Share by Company (2018-2023)
Table 18. Global Pharmaceutical Microcrystalline Cellulose Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Pharmaceutical Microcrystalline Cellulose Revenue Market Share by Company (2018-2023)
Table 20. Global Pharmaceutical Microcrystalline Cellulose Sale Price by Company (2018-2023) & (US$/Ton)
Table 21. Key Manufacturers Pharmaceutical Microcrystalline Cellulose Producing Area Distribution and Sales Area
Table 22. Players Pharmaceutical Microcrystalline Cellulose Products Offered
Table 23. Pharmaceutical Microcrystalline Cellulose Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Pharmaceutical Microcrystalline Cellulose Sales by Geographic Region (2018-2023) & (Tons)
Table 27. Global Pharmaceutical Microcrystalline Cellulose Sales Market Share Geographic Region (2018-2023)
Table 28. Global Pharmaceutical Microcrystalline Cellulose Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Pharmaceutical Microcrystalline Cellulose Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Pharmaceutical Microcrystalline Cellulose Sales by Country/Region (2018-2023) & (Tons)
Table 31. Global Pharmaceutical Microcrystalline Cellulose Sales Market Share by Country/Region (2018-2023)
Table 32. Global Pharmaceutical Microcrystalline Cellulose Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Pharmaceutical Microcrystalline Cellulose Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Pharmaceutical Microcrystalline Cellulose Sales by Country (2018-2023) & (Tons)
Table 35. Americas Pharmaceutical Microcrystalline Cellulose Sales Market Share by Country (2018-2023)
Table 36. Americas Pharmaceutical Microcrystalline Cellulose Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Pharmaceutical Microcrystalline Cellulose Revenue Market Share by Country (2018-2023)
Table 38. Americas Pharmaceutical Microcrystalline Cellulose Sales by Type (2018-2023) & (Tons)
Table 39. Americas Pharmaceutical Microcrystalline Cellulose Sales by Application (2018-2023) & (Tons)
Table 40. APAC Pharmaceutical Microcrystalline Cellulose Sales by Region (2018-2023) & (Tons)
Table 41. APAC Pharmaceutical Microcrystalline Cellulose Sales Market Share by Region (2018-2023)
Table 42. APAC Pharmaceutical Microcrystalline Cellulose Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Pharmaceutical Microcrystalline Cellulose Revenue Market Share by Region (2018-2023)
Table 44. APAC Pharmaceutical Microcrystalline Cellulose Sales by Type (2018-2023) & (Tons)
Table 45. APAC Pharmaceutical Microcrystalline Cellulose Sales by Application (2018-2023) & (Tons)
Table 46. Europe Pharmaceutical Microcrystalline Cellulose Sales by Country (2018-2023) & (Tons)
Table 47. Europe Pharmaceutical Microcrystalline Cellulose Sales Market Share by Country (2018-2023)
Table 48. Europe Pharmaceutical Microcrystalline Cellulose Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Pharmaceutical Microcrystalline Cellulose Revenue Market Share by Country (2018-2023)
Table 50. Europe Pharmaceutical Microcrystalline Cellulose Sales by Type (2018-2023) & (Tons)
Table 51. Europe Pharmaceutical Microcrystalline Cellulose Sales by Application (2018-2023) & (Tons)
Table 52. Middle East & Africa Pharmaceutical Microcrystalline Cellulose Sales by Country (2018-2023) & (Tons)
Table 53. Middle East & Africa Pharmaceutical Microcrystalline Cellulose Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Pharmaceutical Microcrystalline Cellulose Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Pharmaceutical Microcrystalline Cellulose Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Pharmaceutical Microcrystalline Cellulose Sales by Type (2018-2023) & (Tons)
Table 57. Middle East & Africa Pharmaceutical Microcrystalline Cellulose Sales by Application (2018-2023) & (Tons)
Table 58. Key Market Drivers & Growth Opportunities of Pharmaceutical Microcrystalline Cellulose
Table 59. Key Market Challenges & Risks of Pharmaceutical Microcrystalline Cellulose
Table 60. Key Industry Trends of Pharmaceutical Microcrystalline Cellulose
Table 61. Pharmaceutical Microcrystalline Cellulose Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Pharmaceutical Microcrystalline Cellulose Distributors List
Table 64. Pharmaceutical Microcrystalline Cellulose Customer List
Table 65. Global Pharmaceutical Microcrystalline Cellulose Sales Forecast by Region (2024-2029) & (Tons)
Table 66. Global Pharmaceutical Microcrystalline Cellulose Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Pharmaceutical Microcrystalline Cellulose Sales Forecast by Country (2024-2029) & (Tons)
Table 68. Americas Pharmaceutical Microcrystalline Cellulose Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Pharmaceutical Microcrystalline Cellulose Sales Forecast by Region (2024-2029) & (Tons)
Table 70. APAC Pharmaceutical Microcrystalline Cellulose Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Pharmaceutical Microcrystalline Cellulose Sales Forecast by Country (2024-2029) & (Tons)
Table 72. Europe Pharmaceutical Microcrystalline Cellulose Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Pharmaceutical Microcrystalline Cellulose Sales Forecast by Country (2024-2029) & (Tons)
Table 74. Middle East & Africa Pharmaceutical Microcrystalline Cellulose Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Pharmaceutical Microcrystalline Cellulose Sales Forecast by Type (2024-2029) & (Tons)
Table 76. Global Pharmaceutical Microcrystalline Cellulose Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Pharmaceutical Microcrystalline Cellulose Sales Forecast by Application (2024-2029) & (Tons)
Table 78. Global Pharmaceutical Microcrystalline Cellulose Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. International Flavors & Fragrances Basic Information, Pharmaceutical Microcrystalline Cellulose Manufacturing Base, Sales Area and Its Competitors
Table 80. International Flavors & Fragrances Pharmaceutical Microcrystalline Cellulose Product Portfolios and Specifications
Table 81. International Flavors & Fragrances Pharmaceutical Microcrystalline Cellulose Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 82. International Flavors & Fragrances Main Business
Table 83. International Flavors & Fragrances Latest Developments
Table 84. JRS Pharma Basic Information, Pharmaceutical Microcrystalline Cellulose Manufacturing Base, Sales Area and Its Competitors
Table 85. JRS Pharma Pharmaceutical Microcrystalline Cellulose Product Portfolios and Specifications
Table 86. JRS Pharma Pharmaceutical Microcrystalline Cellulose Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 87. JRS Pharma Main Business
Table 88. JRS Pharma Latest Developments
Table 89. Shin-Etsu Chemical Co., Ltd. Basic Information, Pharmaceutical Microcrystalline Cellulose Manufacturing Base, Sales Area and Its Competitors
Table 90. Shin-Etsu Chemical Co., Ltd. Pharmaceutical Microcrystalline Cellulose Product Portfolios and Specifications
Table 91. Shin-Etsu Chemical Co., Ltd. Pharmaceutical Microcrystalline Cellulose Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 92. Shin-Etsu Chemical Co., Ltd. Main Business
Table 93. Shin-Etsu Chemical Co., Ltd. Latest Developments
Table 94. Ashland Basic Information, Pharmaceutical Microcrystalline Cellulose Manufacturing Base, Sales Area and Its Competitors
Table 95. Ashland Pharmaceutical Microcrystalline Cellulose Product Portfolios and Specifications
Table 96. Ashland Pharmaceutical Microcrystalline Cellulose Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 97. Ashland Main Business
Table 98. Ashland Latest Developments
Table 99. Asahi Kasei Basic Information, Pharmaceutical Microcrystalline Cellulose Manufacturing Base, Sales Area and Its Competitors
Table 100. Asahi Kasei Pharmaceutical Microcrystalline Cellulose Product Portfolios and Specifications
Table 101. Asahi Kasei Pharmaceutical Microcrystalline Cellulose Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 102. Asahi Kasei Main Business
Table 103. Asahi Kasei Latest Developments
Table 104. Mingtai Basic Information, Pharmaceutical Microcrystalline Cellulose Manufacturing Base, Sales Area and Its Competitors
Table 105. Mingtai Pharmaceutical Microcrystalline Cellulose Product Portfolios and Specifications
Table 106. Mingtai Pharmaceutical Microcrystalline Cellulose Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 107. Mingtai Main Business
Table 108. Mingtai Latest Developments
Table 109. Huzhou Zhanwang Basic Information, Pharmaceutical Microcrystalline Cellulose Manufacturing Base, Sales Area and Its Competitors
Table 110. Huzhou Zhanwang Pharmaceutical Microcrystalline Cellulose Product Portfolios and Specifications
Table 111. Huzhou Zhanwang Pharmaceutical Microcrystalline Cellulose Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 112. Huzhou Zhanwang Main Business
Table 113. Huzhou Zhanwang Latest Developments
Table 114. Sunhere Pharmaceutical Excipients Basic Information, Pharmaceutical Microcrystalline Cellulose Manufacturing Base, Sales Area and Its Competitors
Table 115. Sunhere Pharmaceutical Excipients Pharmaceutical Microcrystalline Cellulose Product Portfolios and Specifications
Table 116. Sunhere Pharmaceutical Excipients Pharmaceutical Microcrystalline Cellulose Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 117. Sunhere Pharmaceutical Excipients Main Business
Table 118. Sunhere Pharmaceutical Excipients Latest Developments
Table 119. Shandong HEAD Basic Information, Pharmaceutical Microcrystalline Cellulose Manufacturing Base, Sales Area and Its Competitors
Table 120. Shandong HEAD Pharmaceutical Microcrystalline Cellulose Product Portfolios and Specifications
Table 121. Shandong HEAD Pharmaceutical Microcrystalline Cellulose Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 122. Shandong HEAD Main Business
Table 123. Shandong HEAD Latest Developments
Table 124. Lotte Chemicals Basic Information, Pharmaceutical Microcrystalline Cellulose Manufacturing Base, Sales Area and Its Competitors
Table 125. Lotte Chemicals Pharmaceutical Microcrystalline Cellulose Product Portfolios and Specifications
Table 126. Lotte Chemicals Pharmaceutical Microcrystalline Cellulose Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 127. Lotte Chemicals Main Business
Table 128. Lotte Chemicals Latest Developments
Table 129. Shandong Liaocheng E HUA Pharmaceutical Co., Ltd Basic Information, Pharmaceutical Microcrystalline Cellulose Manufacturing Base, Sales Area and Its Competitors
Table 130. Shandong Liaocheng E HUA Pharmaceutical Co., Ltd Pharmaceutical Microcrystalline Cellulose Product Portfolios and Specifications
Table 131. Shandong Liaocheng E HUA Pharmaceutical Co., Ltd Pharmaceutical Microcrystalline Cellulose Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 132. Shandong Liaocheng E HUA Pharmaceutical Co., Ltd Main Business
Table 133. Shandong Liaocheng E HUA Pharmaceutical Co., Ltd Latest Developments
Table 134. Yingkou AODA Pharmaceuticals Basic Information, Pharmaceutical Microcrystalline Cellulose Manufacturing Base, Sales Area and Its Competitors
Table 135. Yingkou AODA Pharmaceuticals Pharmaceutical Microcrystalline Cellulose Product Portfolios and Specifications
Table 136. Yingkou AODA Pharmaceuticals Pharmaceutical Microcrystalline Cellulose Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 137. Yingkou AODA Pharmaceuticals Main Business
Table 138. Yingkou AODA Pharmaceuticals Latest Developments
Table 139. Accent Microcell Basic Information, Pharmaceutical Microcrystalline Cellulose Manufacturing Base, Sales Area and Its Competitors
Table 140. Accent Microcell Pharmaceutical Microcrystalline Cellulose Product Portfolios and Specifications
Table 141. Accent Microcell Pharmaceutical Microcrystalline Cellulose Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 142. Accent Microcell Main Business
Table 143. Accent Microcell Latest Developments
Table 144. Qufu TIANLI MEDICAL Supplements Basic Information, Pharmaceutical Microcrystalline Cellulose Manufacturing Base, Sales Area and Its Competitors
Table 145. Qufu TIANLI MEDICAL Supplements Pharmaceutical Microcrystalline Cellulose Product Portfolios and Specifications
Table 146. Qufu TIANLI MEDICAL Supplements Pharmaceutical Microcrystalline Cellulose Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 147. Qufu TIANLI MEDICAL Supplements Main Business
Table 148. Qufu TIANLI MEDICAL Supplements Latest Developments
Table 149. C & J Chemical Industries Co., Ltd. Basic Information, Pharmaceutical Microcrystalline Cellulose Manufacturing Base, Sales Area and Its Competitors
Table 150. C & J Chemical Industries Co., Ltd. Pharmaceutical Microcrystalline Cellulose Product Portfolios and Specifications
Table 151. C & J Chemical Industries Co., Ltd. Pharmaceutical Microcrystalline Cellulose Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 152. C & J Chemical Industries Co., Ltd. Main Business
Table 153. C & J Chemical Industries Co., Ltd. Latest Developments
List of Figures
Figure 1. Picture of Pharmaceutical Microcrystalline Cellulose
Figure 2. Pharmaceutical Microcrystalline Cellulose Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pharmaceutical Microcrystalline Cellulose Sales Growth Rate 2018-2029 (Tons)
Figure 7. Global Pharmaceutical Microcrystalline Cellulose Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Pharmaceutical Microcrystalline Cellulose Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Particle Size Less Than 50 Microns
Figure 10. Product Picture of Particle Size 50-100 Microns
Figure 11. Product Picture of Particle Size Greater Than 100 Microns
Figure 12. Global Pharmaceutical Microcrystalline Cellulose Sales Market Share by Type in 2022
Figure 13. Global Pharmaceutical Microcrystalline Cellulose Revenue Market Share by Type (2018-2023)
Figure 14. Pharmaceutical Microcrystalline Cellulose Consumed in Sustained Release Preparation
Figure 15. Global Pharmaceutical Microcrystalline Cellulose Market: Sustained Release Preparation (2018-2023) & (Tons)
Figure 16. Pharmaceutical Microcrystalline Cellulose Consumed in Tablet
Figure 17. Global Pharmaceutical Microcrystalline Cellulose Market: Tablet (2018-2023) & (Tons)
Figure 18. Pharmaceutical Microcrystalline Cellulose Consumed in Capsule
Figure 19. Global Pharmaceutical Microcrystalline Cellulose Market: Capsule (2018-2023) & (Tons)
Figure 20. Global Pharmaceutical Microcrystalline Cellulose Sales Market Share by Application (2022)
Figure 21. Global Pharmaceutical Microcrystalline Cellulose Revenue Market Share by Application in 2022
Figure 22. Pharmaceutical Microcrystalline Cellulose Sales Market by Company in 2022 (Tons)
Figure 23. Global Pharmaceutical Microcrystalline Cellulose Sales Market Share by Company in 2022
Figure 24. Pharmaceutical Microcrystalline Cellulose Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Pharmaceutical Microcrystalline Cellulose Revenue Market Share by Company in 2022
Figure 26. Global Pharmaceutical Microcrystalline Cellulose Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Pharmaceutical Microcrystalline Cellulose Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Pharmaceutical Microcrystalline Cellulose Sales 2018-2023 (Tons)
Figure 29. Americas Pharmaceutical Microcrystalline Cellulose Revenue 2018-2023 ($ Millions)
Figure 30. APAC Pharmaceutical Microcrystalline Cellulose Sales 2018-2023 (Tons)
Figure 31. APAC Pharmaceutical Microcrystalline Cellulose Revenue 2018-2023 ($ Millions)
Figure 32. Europe Pharmaceutical Microcrystalline Cellulose Sales 2018-2023 (Tons)
Figure 33. Europe Pharmaceutical Microcrystalline Cellulose Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Pharmaceutical Microcrystalline Cellulose Sales 2018-2023 (Tons)
Figure 35. Middle East & Africa Pharmaceutical Microcrystalline Cellulose Revenue 2018-2023 ($ Millions)
Figure 36. Americas Pharmaceutical Microcrystalline Cellulose Sales Market Share by Country in 2022
Figure 37. Americas Pharmaceutical Microcrystalline Cellulose Revenue Market Share by Country in 2022
Figure 38. Americas Pharmaceutical Microcrystalline Cellulose Sales Market Share by Type (2018-2023)
Figure 39. Americas Pharmaceutical Microcrystalline Cellulose Sales Market Share by Application (2018-2023)
Figure 40. United States Pharmaceutical Microcrystalline Cellulose Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Pharmaceutical Microcrystalline Cellulose Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Pharmaceutical Microcrystalline Cellulose Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Pharmaceutical Microcrystalline Cellulose Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Pharmaceutical Microcrystalline Cellulose Sales Market Share by Region in 2022
Figure 45. APAC Pharmaceutical Microcrystalline Cellulose Revenue Market Share by Regions in 2022
Figure 46. APAC Pharmaceutical Microcrystalline Cellulose Sales Market Share by Type (2018-2023)
Figure 47. APAC Pharmaceutical Microcrystalline Cellulose Sales Market Share by Application (2018-2023)
Figure 48. China Pharmaceutical Microcrystalline Cellulose Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Pharmaceutical Microcrystalline Cellulose Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Pharmaceutical Microcrystalline Cellulose Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Pharmaceutical Microcrystalline Cellulose Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Pharmaceutical Microcrystalline Cellulose Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Pharmaceutical Microcrystalline Cellulose Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Pharmaceutical Microcrystalline Cellulose Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Pharmaceutical Microcrystalline Cellulose Sales Market Share by Country in 2022
Figure 56. Europe Pharmaceutical Microcrystalline Cellulose Revenue Market Share by Country in 2022
Figure 57. Europe Pharmaceutical Microcrystalline Cellulose Sales Market Share by Type (2018-2023)
Figure 58. Europe Pharmaceutical Microcrystalline Cellulose Sales Market Share by Application (2018-2023)
Figure 59. Germany Pharmaceutical Microcrystalline Cellulose Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Pharmaceutical Microcrystalline Cellulose Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Pharmaceutical Microcrystalline Cellulose Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Pharmaceutical Microcrystalline Cellulose Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Pharmaceutical Microcrystalline Cellulose Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Pharmaceutical Microcrystalline Cellulose Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Pharmaceutical Microcrystalline Cellulose Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Pharmaceutical Microcrystalline Cellulose Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Pharmaceutical Microcrystalline Cellulose Sales Market Share by Application (2018-2023)
Figure 68. Egypt Pharmaceutical Microcrystalline Cellulose Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Pharmaceutical Microcrystalline Cellulose Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Pharmaceutical Microcrystalline Cellulose Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Pharmaceutical Microcrystalline Cellulose Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Pharmaceutical Microcrystalline Cellulose Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Pharmaceutical Microcrystalline Cellulose in 2022
Figure 74. Manufacturing Process Analysis of Pharmaceutical Microcrystalline Cellulose
Figure 75. Industry Chain Structure of Pharmaceutical Microcrystalline Cellulose
Figure 76. Channels of Distribution
Figure 77. Global Pharmaceutical Microcrystalline Cellulose Sales Market Forecast by Region (2024-2029)
Figure 78. Global Pharmaceutical Microcrystalline Cellulose Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Pharmaceutical Microcrystalline Cellulose Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Pharmaceutical Microcrystalline Cellulose Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Pharmaceutical Microcrystalline Cellulose Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Pharmaceutical Microcrystalline Cellulose Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の医薬品微結晶セルロース市場予測 2023年-2029年] (コード：LP23DC02438)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の医薬品微結晶セルロース市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のベジタリアンセルロースカプセル市場予測 2023年-2029年
  • 世界の微結晶石市場予測 2023年-2029年
  • 世界の吸収性再生酸化セルロース市場予測 2023年-2029年
  • 世界の医療用微結晶性セルロース市場2022年：木材パルプ系、精製綿系
  • 世界の微生物セルロース市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆